Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2013-03-19 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CALAIS (62100), Pas-de-Calais
PHARMACIE BOUCHEZ : revenue, balance sheet and financial ratios
PHARMACIE BOUCHEZ is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CALAIS (62100),
this company of category PME
shows in 2022 a revenue of 2.6 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BOUCHEZ (SIREN 792077208)
Indicator
2023
2022
2021
2019
2018
2017
2016
2015
Revenue
N/C
2 639 451 €
N/C
N/C
N/C
N/C
N/C
2 450 636 €
Net income
137 600 €
123 010 €
138 826 €
102 995 €
92 542 €
113 648 €
110 612 €
103 543 €
EBITDA
N/C
167 830 €
N/C
N/C
N/C
N/C
N/C
190 438 €
Net margin
N/C
4.7%
N/C
N/C
N/C
N/C
N/C
4.2%
Revenue and income statement
In 2023, PHARMACIE BOUCHEZ generates positive net income of 138 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2023: 104 k€ -> 138 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
137 600 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 71%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 47%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
71.016%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
46.738%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2021
2022
2023
Debt ratio
1329.933
681.664
427.206
306.143
236.07
126.949
95.027
71.016
Financial autonomy
5.845
10.913
16.37
20.727
24.872
37.122
39.75
46.738
Repayment capacity
12.985
None
None
None
None
None
7.548
None
Cash flow / Revenue
5.4%
None%
None%
None%
None%
None%
4.419%
None%
Sector positioning
Debt ratio
71.022023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average-7 pts over 3 years
In 2023, the debt ratio of PHARMACIE BOUCHEZ (71.02) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
46.74%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average+8 pts over 3 years
In 2023, the financial autonomy of PHARMACIE BOUCHEZ (46.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
7.55 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE BOUCHEZ (7.55) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 91.59. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
91.592
Liquidity indicators evolution PHARMACIE BOUCHEZ
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2019
2021
2022
2023
Liquidity ratio
74.654
89.456
91.857
79.393
93.246
81.64
88.124
91.592
Interest coverage
14.066
None
None
None
None
None
9.135
None
Sector positioning
Liquidity ratio
91.592023
2021
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Watch
In 2023, the liquidity ratio of PHARMACIE BOUCHEZ (91.59) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
9.13x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE BOUCHEZ (9.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE BOUCHEZ
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2019
2021
2022
2023
Operating WCR
141 230 €
0 €
0 €
0 €
0 €
0 €
313 910 €
0 €
Inventory turnover (days)
31
0
0
0
0
0
28
0
Customer payment term (days)
2
0
0
0
0
0
8
0
Supplier payment term (days)
45
0
0
0
0
0
77
0
Positioning of PHARMACIE BOUCHEZ in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE BOUCHEZ is estimated at
1 623 607 €
(range 987 393€ - 2 282 428€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
987k€1623k€2282k€
1 623 607 €Range: 987 393€ - 2 282 428€
NAF 5 année 2023
Valuation method used
Net Income Multiple
137 600 €
×
11.8x
=1 623 608 €
Range: 987 394€ - 2 282 428€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BOUCHEZ with other companies in the same sector:
Frequently asked questions about PHARMACIE BOUCHEZ
What is the revenue of PHARMACIE BOUCHEZ ?
The revenue of PHARMACIE BOUCHEZ in 2022 is 2.6 M€.
Is PHARMACIE BOUCHEZ profitable?
Yes, PHARMACIE BOUCHEZ generated a net profit of 138 k€ in 2023.
Where is the headquarters of PHARMACIE BOUCHEZ ?
The headquarters of PHARMACIE BOUCHEZ is located in CALAIS (62100), in the department Pas-de-Calais.
Where to find the tax return of PHARMACIE BOUCHEZ ?
The tax return of PHARMACIE BOUCHEZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BOUCHEZ operate?
PHARMACIE BOUCHEZ operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart